Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00669318

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Completed

Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer

NCT01691040

Conditions: Anemia, Anemia of Chronic Disease, Blood Protein Disorders, +16 more
Locations: University Hospital Graz, Austria

AKH Vienna Vienna, Austria

Wilhelminenspital Vienna, Austria

University Hospital Plovdiv, Bulgaria

View Trial Details

Completed

Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT

NCT00586703

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Duke University Health Systems Durham, North Carolina, United States

View Trial Details

Completed

Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

NCT00580034

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: Duke University Health Systems Durham, North Carolina, United States

View Trial Details

Completed

Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants

NCT00606437

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma

NCT01131221

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma

NCT00069758

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Comprehensive Cancer Center-Desert Regional Medical Center Palm Springs, California, United States

San Diego Cancer Center Vista, California, United States

Georgetown University Medical Center - Lombardi Cancer Center Washington D.C., District of Columbia, United States

View all 17 locations

View Trial Details

Completed

Longitudinal Survey Analysis in Lymphoma Survivors

NCT01469754

Conditions: Coping, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: New York Presbyterian/Weill Cornell Center for Lymphoma and Myeloma New York, United States

View Trial Details

Completed

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

NCT00003572

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +46 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003962

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions